100 related articles for article (PubMed ID: 1560227)
21. Sodium-dependent uptake of nucleosides by dissociated brain cells from the rat.
Johnston ME; Geiger JD
J Neurochem; 1989 Jan; 52(1):75-81. PubMed ID: 2908894
[TBL] [Abstract][Full Text] [Related]
22. Adenine/ribose supply increases adenosine production and protects ATP pool in adenosine kinase-inhibited cardiac cells.
Smolenski RT; Kalsi KK; Zych M; Kochan Z; Yacoub MH
J Mol Cell Cardiol; 1998 Mar; 30(3):673-83. PubMed ID: 9515042
[TBL] [Abstract][Full Text] [Related]
23. Characterization of [35S]-ATP alpha S and [3H]-alpha, beta-MeATP binding sites in rat brain cortical synaptosomes: regulation of ligand binding by divalent cations.
Schäfer R; Reiser G
Br J Pharmacol; 1997 Jul; 121(5):913-22. PubMed ID: 9222547
[TBL] [Abstract][Full Text] [Related]
24. Dual cardiac microdialysis to assess drug-induced changes in interstitial purine metabolites: adenosine deaminase inhibition versus adenosine kinase inhibition.
Manthei SA; Reiling CM; Van Wylen DG
Cardiovasc Res; 1998 Jan; 37(1):171-8. PubMed ID: 9539871
[TBL] [Abstract][Full Text] [Related]
25. Effects of nucleoside transport inhibitors and adenine/ribose supply on ATP concentration and adenosine production in cardiac myocytes.
Kalsi KK; Smolenski RT; Yacoub MH
Mol Cell Biochem; 1998 Mar; 180(1-2):193-9. PubMed ID: 9546646
[TBL] [Abstract][Full Text] [Related]
26. Differential cardioprotection with selective inhibitors of adenosine metabolism and transport: role of purine release in ischemic and reperfusion injury.
Abd-Elfattah AS; Jessen ME; Lekven J; Wechsler AS
Mol Cell Biochem; 1998 Mar; 180(1-2):179-91. PubMed ID: 9546645
[TBL] [Abstract][Full Text] [Related]
27. Renal interstitial adenosine metabolism during ischemia in dogs.
Nishiyama A; Kimura S; He H; Miura K; Rahman M; Fujisawa Y; Fukui T; Abe Y
Am J Physiol Renal Physiol; 2001 Feb; 280(2):F231-8. PubMed ID: 11208598
[TBL] [Abstract][Full Text] [Related]
28. Kinetics of dopamine and noradrenaline transport in synaptosomes from cerebellum, striatum and frontal cortex of normal and reeler mice.
Efthimiopoulos S; Giompres P; Valcana T
J Neurosci Res; 1991 Aug; 29(4):510-9. PubMed ID: 1838778
[TBL] [Abstract][Full Text] [Related]
29. Co-administration of adenosine kinase and deaminase inhibitors produces supra-additive potentiation of N-methyl-D-aspartate-evoked adenosine formation in cortex.
Hebb MO; White TD
Eur J Pharmacol; 1998 Mar; 344(2-3):121-5. PubMed ID: 9600645
[TBL] [Abstract][Full Text] [Related]
30. Adenosine transport in perfused rat kidney and renal cortical membrane vesicles.
Trimble ME; Coulson R
Am J Physiol; 1984 Jun; 246(6 Pt 2):F794-803. PubMed ID: 6742130
[TBL] [Abstract][Full Text] [Related]
31. Blood-brain barrier transport and brain metabolism of adenosine and adenosine analogs.
Pardridge WM; Yoshikawa T; Kang YS; Miller LP
J Pharmacol Exp Ther; 1994 Jan; 268(1):14-8. PubMed ID: 8301550
[TBL] [Abstract][Full Text] [Related]
32. Nucleoside transporter-mediated uptake and release of [3H]L-adenosine in DDT1 MF-2 smooth muscle cells.
Foga IO; Geiger JD; Parkinson FE
Eur J Pharmacol; 1996 Dec; 318(2-3):455-60. PubMed ID: 9016938
[TBL] [Abstract][Full Text] [Related]
33. Cardioprotection with adenosine metabolism inhibitors in ischemic-reperfused mouse heart.
Peart J; Matherne GP; Cerniway RJ; Headrick JP
Cardiovasc Res; 2001 Oct; 52(1):120-9. PubMed ID: 11557240
[TBL] [Abstract][Full Text] [Related]
34. Increases in interstitial adenosine and cerebral blood flow with inhibition of adenosine kinase and adenosine deaminase.
Sciotti VM; Van Wylen DG
J Cereb Blood Flow Metab; 1993 Mar; 13(2):201-7. PubMed ID: 8436611
[TBL] [Abstract][Full Text] [Related]
35. Adenosine transport by a variant of C1300 murine neuroblastoma cells deficient in adenosine kinase.
Green RD
Biochim Biophys Acta; 1980 May; 598(2):366-74. PubMed ID: 6246950
[TBL] [Abstract][Full Text] [Related]
36. Transport and metabolism of adenosine in the perfused guinea-pig placenta.
Wheeler CP; Yudilevich DL
J Physiol; 1988 Nov; 405():511-26. PubMed ID: 3255799
[TBL] [Abstract][Full Text] [Related]
37. Irreversible binding and recovery of the norepinephrine uptake system using an alkylating derivative of norepinephrine.
Baker SP; Standifer KM; Kalberg CJ; Pitha J; Sumners C
J Neurochem; 1988 Apr; 50(4):1044-52. PubMed ID: 2894406
[TBL] [Abstract][Full Text] [Related]
38. Erythro-9-(2-hydroxy-3-nonyl)adenine inhibits cyclic-3',5'-guanosine monophosphate-stimulated phosphodiesterase to reverse hypoxic pulmonary vasoconstriction in the perfused rat lung.
Haynes J; Killilea DW; Peterson PD; Thompson WJ
J Pharmacol Exp Ther; 1996 Feb; 276(2):752-7. PubMed ID: 8632346
[TBL] [Abstract][Full Text] [Related]
39. High affinity glutamate transport in rat cortical neurons in culture.
Wang GJ; Chung HJ; Schnuer J; Pratt K; Zable AC; Kavanaugh MP; Rosenberg PA
Mol Pharmacol; 1998 Jan; 53(1):88-96. PubMed ID: 9443935
[TBL] [Abstract][Full Text] [Related]
40. Quantification of extracellular and intracellular adenosine production: understanding the transmembranous concentration gradient.
Deussen A; Stappert M; Schäfer S; Kelm M
Circulation; 1999 Apr; 99(15):2041-7. PubMed ID: 10209010
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
